SCHEMBL3851736

SCHEMBL3851736

CSCC(=O)N1CCOC1=O

nearest known ligand 0.57

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 14/20 0.56
FAAH O00519 6/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL675612 0.80 NAAA (0.64) NAAAFAAH
SCHEMBL12999946 0.77 NAAA (0.75) NAAAFAAH
SCHEMBL13168689 0.77 NAAA (0.56) NAAAFAAH
SCHEMBL10706028 0.76 NAAA (0.54) NAAAFAAH
SCHEMBL21729359 0.76 NAAA (0.54) NAAAFAAH
SCHEMBL8383580 0.76 NAAA (0.54) NAAAFAAH
SCHEMBL13335283 0.76 NAAA (0.54) NAAAFAAH
SCHEMBL1973483 0.76 NAAA (0.54) NAAAFAAH
SCHEMBL19825342 0.76 NAAA (0.80) NAAAFAAH
SCHEMBL25510474 0.76 NAAA (0.54) NAAAFAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1412323-B1 PROTECTED 3,5-DIHYDROXY-2,2-DIMETHYL-VALERONITRILES FOR THE SYNTHESIS OF EPOTHILONES AND DERIVATIVES AND METHOD FOR THE PRODUCTION AND USE THEREOF BAYER SCHERING PHARMA AG (DE) 2009-09-30 EP disclosed
US-20080161580-A1 PROTECTED 3,5-DIHYDROXY-2,2-DIMETHYL-VALEROAMIDES FOR THE SYNTHESIS OF EPOTHILONES AND DERIVATIVES AND PROCESS FOR THE PRODUCTION AND THE USE WESTERMANN JURGEN 2008-07-03 US disclosed
US-7368568-B2 Protected 3,5-dihydroxy-2,2-dimethyl-valeroamides for the synthesis of epothilones and derivatives and process for production and the use BAYER SCHERING PHARMA AG (DE) 2008-05-06 US disclosed
US-7358382-B2 Protected 3,5-dihydroxy-2,2-dimethyl-valeronitriles for the synthesis of epothilones and epothilone derivatives and process for the production BAYER SCHERING PHARMA AG (DE) 2008-04-15 US disclosed
US-7034165-B2 Protected 3,-5-dihydroxy-2,2-dimethyl-valeronitriles for the synthesis of epothilones and epothilone derivatives and process for the production SCHERING AG (DE) 2006-04-25 US disclosed
US-20050272731-A1 Protected 3,5-dihydroxy-2,2-dimethyl-valeroamides for the synthesis of epothilones and derivatives and process for production and the use BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2005-12-08 US disclosed
US-20050267306-A1 Protected 3,5-dihydroxy-2,2-dimethyl-valeronitriles for the synthesis of epothilones and epothilone derivatives and process for the production BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2005-12-01 US disclosed
US-6933385-B2 Protected 3,5-dihydroxy-2,2-dimethyl-valeroamides for the synthesis of epothilones and derivatives and process for the production and the use SCHERING AG (DE) 2005-08-23 US disclosed
EP-1412323-A1 PROTECTED 3,5-DIHYDROXY-2,2-DIMETHYL-VALERONITRILES FOR THE SYNTHESIS OF EPOTHILONES AND DERIVATIVES AND METHOD FOR THE PRODUCTION AND USE THEREOF Schering Aktiengesellschaft (DE) 2004-04-28 EP disclosed
EP-1412322-A2 PROTECTED 3.5-DIHYDROXY-2.2-DIMETHYL-VALEROAMIDES FOR THE SYNTHESIS OF EPOTHILONE AND DERIVATIVES AND METHOD FOR THE PRODUCTION AND USE THEREOF Schering Aktiengesellschaft (DE) 2004-04-28 EP disclosed
US-20030158412-A1 Protected 3,5-dihydroxy-2,2-dimethyl-valeroamides for the synthesis of epothilones and derivatives and process for the production and the use SCHERING AKTIENGESELLSCHAFT (DE) 2003-08-21 US disclosed
US-20030149281-A1 Protected 3,-5-dihydroxy-2,2-dimethyl-valeronitriles for the synthesis of epothilones and epothilone derivatives and process for the production SCHERING AG (DE) 2003-08-07 US disclosed
WO-2003014063-A2 PROTECTED 3.5-DIHYDROXY-2.2-DIMETHYL-VALEROAMIDES FOR THE SYNTHESIS OF EPOTHILONE AND DERIVATIVES AND METHOD FOR THE PRODUCTION AND USE THEREOF SCHERING AKTIENGESELLSCHAFT (DE) 2003-02-20 WO disclosed
WO-2003014068-A1 PROTECTED 3.5-DIHYDROXY-2.2-DIMETHYL-VALERONITRILES FOR THE SYNTHESIS OF EPOTHILONES AND DERIVATIVES AND METHOD FOR THE PRODUCTION AND USE THEREOF SCHERING AKTIENGESELLSCHAFT (DE) 2003-02-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080161580-A1 PROTECTED 3,5-DIHYDROXY-2,2-DIMETHYL-VALEROAMIDES FOR THE SYNTHESIS OF EPOTHILONES AND DERIVATIVES AND PROCESS FOR THE PRODUCTION AND THE USE DHPS, VARS1, CYP51A1 NAAA 1247/4885FAAH 1569/4885
US-20050267306-A1 Protected 3,5-dihydroxy-2,2-dimethyl-valeronitriles for the synthesis of epothilones and epothilone derivatives and process for the production DHPS, VARS1, CYP51A1 NAAA 3459/4885FAAH 3718/4885
US-20030158412-A1 Protected 3,5-dihydroxy-2,2-dimethyl-valeroamides for the synthesis of epothilones and derivatives and process for the production and the use DHPS, VARS1, CYP51A1 NAAA 1247/4885FAAH 1569/4885
US-20050272731-A1 Protected 3,5-dihydroxy-2,2-dimethyl-valeroamides for the synthesis of epothilones and derivatives and process for production and the use DHPS, VARS1, HSD17B12 NAAA 2061/4885FAAH 3063/4885
US-20030149281-A1 Protected 3,-5-dihydroxy-2,2-dimethyl-valeronitriles for the synthesis of epothilones and epothilone derivatives and process for the production DHPS, VARS1, CYP51A1 NAAA 3483/4885FAAH 3725/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.